Digital Solutions in Clinical Trials
This presentation discusses the digital solutions that may be leverage in clinical trials at WU, and includes considerations for drug and device trials using digital solutions (e.g., FDA 21 CFR Part 11, referred to as “Part 11”).
Speaker:
